REAL-WORLD EFFECTIVENESS OF DUPILUMAB ON PATIENT-REPORTED OUTCOMES AND SYMPTOMS IN ASTHMA: 3-MONTH FOLLOW-UP DATA FROM RESPIRE, AN OBSERVATIONAL STUDY WITH PATIENTS RECRUITED FROM A US DUPILUMAB PATIENT SUPPORT PROGRAM